These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4197229)

  • 21. [Clinical studies on the bacterial resistance to rifampicin].
    Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 Dec; 47(12):475-9. PubMed ID: 4631478
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-mycobacterial activity of rifampicin].
    Gialdroni Grassi G
    G Ital Mal Torace; 1971; 25(2):77-88. PubMed ID: 5003253
    [No Abstract]   [Full Text] [Related]  

  • 23. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 24. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 25. Rifampicin resistance in tuberculosis outbreak, London, England.
    Jenkins C
    Emerg Infect Dis; 2005 Jun; 11(6):931-4. PubMed ID: 15963290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detecting rpoB gene mutation in rifampin-resistant Mycobacterium tuberculosis by using the reverse dot-blot hybridization method].
    Wang W; Pan W; Jin W; Weng X; Yan R; Su B; Chen S; Zhang W; Lu H; Qi Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Oct; 25(10):591-4. PubMed ID: 12490124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
    Gagneux S; Long CD; Small PM; Van T; Schoolnik GK; Bohannan BJ
    Science; 2006 Jun; 312(5782):1944-6. PubMed ID: 16809538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN; Kolomytseva OS; Gur'ian IE
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis.
    Park YK; Kim BJ; Ryu S; Kook YH; Choe YK; Bai GH; Kim SJ
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):166-70. PubMed ID: 11931418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis].
    Rinder H
    Pneumologie; 1998 Feb; 52(2):91-2. PubMed ID: 9557056
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
    Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 33. Proteosynthetic activity of isolated ribosomes of Mycobacteria and its alteration by rifampicin and related tuberculostatic drugs.
    Trnka L; Smith DW
    Antibiot Chemother; 1970; 16():369-79. PubMed ID: 4108893
    [No Abstract]   [Full Text] [Related]  

  • 34. Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
    Raleigh JW; Wichelhausen R
    Am Rev Respir Dis; 1973 Sep; 108(3):639-42. PubMed ID: 4200815
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rifampicin and its sodium salt in experimental tuberculosis of albino mice].
    Pershin GN; Kutchek SN; Zykova TN
    Farmakol Toksikol; 1972; 35(3):342-7. PubMed ID: 4625834
    [No Abstract]   [Full Text] [Related]  

  • 37. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
    Djurisić M; Davidović C; Leposavić M; Jovancvić M; Marković L; Popović S
    Plucne Bolesti Tuberk; 1973; 25(3):251-6. PubMed ID: 4210992
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of clinical characteristics between rifampin-dependent and rifampin- resistant patients with pulmonary tuberculosis].
    Li Y; Tan S; Luo C; Li Y; Qin H; Feng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):287-9. PubMed ID: 23443791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 40. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.